Health
Pfizer-BioNTech COVID-19 Vaccine Achieves 100% Effectiveness in Adolescents – Contagionlive.com
The newest data for the real-world assessment show the mRNA vaccine provides greater immunogenicity in persons aged 12-15 years old than in young adults.
Pfizer-BioNTech COVID-19 vaccine BNT162b2 provided an observed vaccine efficacy of 100% among adolescents aged 12-15 years old after 7 days post-administration with the 2-dose product.
The new findings from an ongoing, placebo-controlled, observer-blinded assessment of the mRNA vaccine in adolescent patients suggest BNT162b2 provides an even greater immune response in the population than that observed in vaccinated young adults.
Led by Robert W. Frenck, Jr., MD, of the Cincinnati Childrens Hospital,…
-
General15 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoBarn-owl project reducing farmers’ reliance on poison to manage rats and mice
-
Noosa News19 hours agoSouth-west Queensland highway closed after truck carrying oxygen cylinders catches fire
-
Noosa News15 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba